BioBoneNCT06658379
Prospective Validation Study of the CD8+TEMRA Cells As a Prognostic Biomarker of Healing Outcome After Fracture
StatusUnknown
PhaseNot specified
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Clinical assessement of the fracture consolidation at first study endpoint based on radiological images
Timeframe: From surgery to 19 weeks post surgery
Secondary (1)
clinical assessement of the fracture consolidation at second study endpoint based on radiological images
Arms and interventions
fracture cohort
Humerus fracture, forearm fracture, femoral fracture. tibia fracture
Diagnostic tests: CD8+TEMRA
Sites
7 sites in 1 country